UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Etoposide: four decades of development of a topoisomerase II inhibitor

European journal of cancer (1990), 1998-09, Vol.34 (10), p.1514-1521

Hande, K.R

1998

Volltextzugriff (PDF)

Chromosome 19 Translocation, Overexpression of Notch3, and Human Lung Cancer

JNCI : Journal of the National Cancer Institute, 2000-08, Vol.92 (16), p.1355-1357

2000

Volltextzugriff (PDF)

Paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a phase II trial

Journal of clinical oncology, 1996-07, Vol.14 (7), p.2054-2060

1996

Volltextzugriff (PDF)

Acute tumor lysis syndrome in patients with high-grade non-Hodgkin's lymphoma

The American journal of medicine, 1993-02, Vol.94 (2), p.133-139

1993

Volltextzugriff (PDF)

A phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non–small-cell lung cancer (a Vanderbilt cancer center affiliate network study)

International journal of radiation oncology, biology, physics, 2000-07, Vol.47 (4), p.931-937

2000

Volltextzugriff (PDF)

Clinical applications of anticancer drugs targeted to topoisomerase II

BBA - Gene Structure and Expression, 1998-10, Vol.1400 (1), p.173-184

Hande, Kenneth R.

1998

Volltextzugriff (PDF)

Bioavailability of low-dose oral etoposide

Journal of clinical oncology, 1993-02, Vol.11 (2), p.374-377

1993

Volltextzugriff (PDF)

Phase I trial of outpatient weekly docetaxel, carboplatin and concurrent thoracic radiation therapy for stage III unresectable non-small-cell lung cancer: a Vanderbilt cancer center affiliate network (VCCAN) trial

Lung cancer (Amsterdam, Netherlands), 2001-12, Vol.34 (3), p.441-449

2001

Volltextzugriff (PDF)

New Drugs on the Horizon: Matrix Metalloproteinase Inhibitors

Stem cells (Dayton, Ohio), 1999-01, Vol.17 (4), p.237-240

1999

Volltextzugriff (PDF)

Severe allopurinol toxicity: Description and guidelines for prevention in patients with renal insufficiency

The American journal of medicine, 1984, Vol.76 (1), p.47-56

1984

Volltextzugriff (PDF)

Prolonged administration of oral etoposide in patients with relapsed or refractory small-cell lung cancer: a phase II trial

Journal of clinical oncology, 1990-10, Vol.8 (10), p.1613-1617

1990

Volltextzugriff (PDF)

Etoposide pharmacology

Seminars in oncology, 1992-12, Vol.19 (6), p.3-9

HANDE, K. R

1992

Volltextzugriff (PDF)

Prolonged administration of oral etoposide in non-small-cell lung cancer: a phase II trial

Journal of clinical oncology, 1992-02, Vol.10 (2), p.292-296

1992

Volltextzugriff (PDF)

Combined small-cell and non-small-cell lung cancer

Journal of clinical oncology, 1989-05, Vol.7 (5), p.607-612

1989

Volltextzugriff (PDF)

Prolonged administration of low-dose, infusional etoposide in patients with etoposide-sensitive neoplasms: a phase I/II study

Journal of clinical oncology, 1993-07, Vol.11 (7), p.1322-1328

1993

Volltextzugriff (PDF)

High-Dose Etoposide and Cyclophosphamide Without Bone Marrow Transplantation for Resistant Hematologic Malignancy

Blood, 1990-08, Vol.76 (3), p.473-479

1990

Volltextzugriff (PDF)

Pharmacokinetics of an intravenous-oral versus intravenous-mesna regimen in lung cancer patients receiving ifosfamide

Journal of clinical oncology, 1998-02, Vol.16 (2), p.616-621

1998

Volltextzugriff (PDF)

Acute vascular ischemic events after cisplatin-based combination chemotherapy for germ-cell tumors of the testis

Annals of internal medicine, 1986-07, Vol.105 (1), p.48

1986

Volltextzugriff (PDF)

The syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in small-cell lung cancer

Journal of clinical oncology, 1986-08, Vol.4 (8), p.1191-1198

1986

Volltextzugriff (PDF)

Paclitaxel plus carboplatin for advanced lung cancer : preliminary results of a Vanderbilt University phase II trial : LUN-46

Seminars in oncology, 1995-08, Vol.22 (4), p.30-33

1995

Volltextzugriff (PDF)

Paclitaxel/5-fluorouracil/leucovorin in metastatic breast cancer : A Vanderbilt cancer center phase II trial

Seminars in oncology, 1997-08, Vol.24 (4), p.S11-20

1997

Volltextzugriff (PDF)

A randomized Phase II trial in patients with carcinoma of an unknown primary site

Cancer, 2001-02, Vol.91 (3), p.592-597

2001

Volltextzugriff (PDF)

Paclitaxel plus carboplatin in the treatment of patients with advanced lung cancer : A Vanderbilt University Cancer Center phase II trial (LUN-46)

Seminars in oncology, 1996-12, Vol.23 (6), p.42-46

1996

Volltextzugriff (PDF)

Non-Hodgkin's lymphoma of the gastrointestinal tract: an analysis of clinical and pathologic features affecting outcome

Journal of clinical oncology, 1988-07, Vol.6 (7), p.1125-1133

1988

Volltextzugriff (PDF)

Treatment of poor-prognosis extensive disease small-cell lung cancer with an all-oral regimen of etoposide and cyclophosphamide : a Southwest Oncology Group clinical and pharmacokinetic study

Cancer chemotherapy and pharmacology, 1999, Vol.44 (6), p.461-468

1999

Volltextzugriff (PDF)

1 – 25 von 241

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(219)
Mit Volltextzugriff
(187)

Publikationsform

Sprache

Englisch
(239)
Deutsch
(1)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(178)
Life Sciences & Biomedicine
(158)
Humans
(147)
Male
(86)
Female
(83)
Oncology
(77)
Biological And Medical Sciences
(72)
Medical Sciences
(71)
Middle Aged
(69)
Adult
(61)
Aged
(54)
Pharmacology. Drug Treatments
(53)
Antineoplastic Agents
(40)
Lung Neoplasms - Drug Therapy
(37)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(35)
Animals
(33)
Chemotherapy
(29)
Etoposide - Administration & Dosage
(26)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(20)
Carcinoma, Small Cell - Drug Therapy
(19)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Etoposide: four decades of development of a topoisomerase II inhibitor

Chromosome 19 Translocation, Overexpression of Notch3, and Human Lung Cancer

Paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a phase II trial

Acute tumor lysis syndrome in patients with high-grade non-Hodgkin's lymphoma

A phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non–small-cell lung cancer (a Vanderbilt cancer center affiliate network study)

Clinical applications of anticancer drugs targeted to topoisomerase II

Bioavailability of low-dose oral etoposide

Phase I trial of outpatient weekly docetaxel, carboplatin and concurrent thoracic radiation therapy for stage III unresectable non-small-cell lung cancer: a Vanderbilt cancer center affiliate network (VCCAN) trial

New Drugs on the Horizon: Matrix Metalloproteinase Inhibitors

Severe allopurinol toxicity: Description and guidelines for prevention in patients with renal insufficiency

Prolonged administration of oral etoposide in patients with relapsed or refractory small-cell lung cancer: a phase II trial

Etoposide pharmacology

Prolonged administration of oral etoposide in non-small-cell lung cancer: a phase II trial

Combined small-cell and non-small-cell lung cancer

Prolonged administration of low-dose, infusional etoposide in patients with etoposide-sensitive neoplasms: a phase I/II study

High-Dose Etoposide and Cyclophosphamide Without Bone Marrow Transplantation for Resistant Hematologic Malignancy

Pharmacokinetics of an intravenous-oral versus intravenous-mesna regimen in lung cancer patients receiving ifosfamide

Acute vascular ischemic events after cisplatin-based combination chemotherapy for germ-cell tumors of the testis

The syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in small-cell lung cancer

Paclitaxel plus carboplatin for advanced lung cancer : preliminary results of a Vanderbilt University phase II trial : LUN-46

Paclitaxel/5-fluorouracil/leucovorin in metastatic breast cancer : A Vanderbilt cancer center phase II trial

A randomized Phase II trial in patients with carcinoma of an unknown primary site

Paclitaxel plus carboplatin in the treatment of patients with advanced lung cancer : A Vanderbilt University Cancer Center phase II trial (LUN-46)

Non-Hodgkin's lymphoma of the gastrointestinal tract: an analysis of clinical and pathologic features affecting outcome

Treatment of poor-prognosis extensive disease small-cell lung cancer with an all-oral regimen of etoposide and cyclophosphamide : a Southwest Oncology Group clinical and pharmacokinetic study

Suchergebnisse filtern